| Common Stock, Shares Authorized |
750M |
shares |
0% |
Q2 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
39M |
shares |
+12% |
Q2 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
584 |
USD |
|
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
1.18M |
USD |
+3.67% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
1.18M |
USD |
+3.67% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
130M |
shares |
0% |
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
5.2M |
USD |
+0.81% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2025 |
FY 2025 |
| Interest Expense |
5.31K |
USD |
+47.9% |
Q1 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2025 |